20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants
NCT04379713
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1511
Enrollment
INDUSTRY
Sponsor class
Conditions
Pneumococcal Disease
Interventions
BIOLOGICAL:
20-valent pneumococcal conjugate vaccine
BIOLOGICAL:
13-valent pneumococcal conjugate vaccine
Sponsor
Pfizer